Medication refill safety workflow

Refill-focused workflow to reduce prescribing drift, interaction risk, and missed monitoring in routine renewal visits.

Medium-risk workflowLast reviewed September 4, 2026

AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.

Scope

Use for

Outpatient medication refill encounters for clinically stable patients needing renewal decisions.

Not for

Ask the patient or care partner what is actually taken, including dose, route, frequency, PRN use, OTC products, and supplements; verify against another reliable source such as the pharmacy record.
Resolve differences between the chart, dispensing history, and actual use, especially after a hospital discharge or specialist change.
Confirm indication, benefit, adverse effects, allergies, adherence/access barriers, and drug-specific monitoring before renewal.

Treat these as urgent. Escalate early if concern persists or follow-up is unreliable.

Suspected serious toxicity, severe adverse reaction, or clinical instability: assess urgently and use the appropriate emergency pathway.
Missing monitoring, duplicate therapy, or a major interaction needs a documented clinical decision before routine renewal; assess both continuation and interruption risks.

Reconcile discrepancies with the responsible prescriber/pharmacist rather than copying an old list. Agree which drugs continue, change, or stop and communicate an updated list.
Set refill quantity and monitoring to the medicine and clinical context. Do not abruptly interrupt dependence-forming or essential therapy solely because routine monitoring is overdue; arrange a safe individualized bridging or taper plan when needed.
If illness requires temporary medication holds, document when and how to restart and who will reassess.

Assign responsibility and a date for outstanding tests and results review; arrange earlier review after changes or possible adverse effects.
Confirm the patient understands the final regimen and can obtain it; include specific contact and escalation instructions.

Return precautions you can say as written:

“If symptoms get worse, new warning signs appear, or you cannot follow the plan from this visit, seek urgent care now.”

Point to the red flags above that apply to this patient.
Confirm follow-up timing and where to go after hours.
Attach a relevant handout to reinforce the plan.
Document disposition, rationale, unresolved uncertainty, and that precautions were understood.

Clinical owner: Family Medicine Editorial Team
Risk tier: Medium
Review cadence: Every 6 months
Last reviewed: September 4, 2026AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
Review status: Evidence current. Next review due March 4, 2027.